ALIVE Israel Healthtech Fund News
7 articles
growth-positive
Navina equips clinicians and care teams with real-time, data-driven insights that improve the quality of care and financial outcomes.
Navina, an Israeli AI-powered clinical intelligence company, has completed a $55 million Series C financing round led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors. The funds will be used to expand in the US healthcare market, further develop AI technology, and improve patient outcomes. Navinas platform, which serves over 10,000 healthcare professionals across 1,300 clinics, has secured partnerships with industry leaders like agilon health and InnovaCare Health. The company is recognized for its high customer satisfaction and trust, and its AI copilot is a trusted solution for value-based care organizations.
InvestmentPartnersCustomers
growth-positive
Magenta Medical Closes $105M Financing Led by Novo Holdings
Magenta Medical, a developer of the Elevate™ heart pump, has secured $105 million in a financing round led by Novo Holdings, with participation from new investors Viking Global Investors and RA Capital Management, as well as existing investors. The funding will support Magentas U.S. clinical programs and efforts to secure FDA approval for the Elevate™ System, designed for high-risk percutaneous coronary interventions. The Elevate™ pump, noted for its small size and minimally invasive placement, has been granted Breakthrough Device Designation by the FDA. Magenta aims to disrupt the mechanical circulatory support market with its innovative technology.
InvestmentProduct Stage
growth-positive
Innovalve acquired for $300 million in cash by medical device giant Edwards Lifesciences | CTech
Innovalve Bio Medical, an Israeli startup specializing in artificial mitral valve technology, is being acquired by Edwards Lifesciences for approximately $300 million. Innovalves technology, which allows for minimally invasive heart valve replacement, has received FDA approval for clinical studies and has been successfully used in over 40 surgeries. The acquisition is expected to be completed by the end of 2024. Innovalve has raised around $30 million from investors including ALIVE VC, OurCrowd, and CBG Group. The acquisition marks a significant exit for the ALIVE fund, highlighting the growing impact of Israeli innovation in the medical technology sector.
Acquired-byFDA approved/pending approval
growth-positive
מנורה מבטחים מצטרפת להשקעה בקרן הבריאות ALIVE כלכליסט
מנורה מבטחים הצטרפה להשקעה בקרן ALIVE, קרן ה-HealthTech שייסד פרופ ארי שמיס. הקרן הוקמה על ידי פרופ ארי שמיס ומיועדת לעמוד על 150 מיליון דולר. מנורה מבטחים תשקיע כ-20 מיליון דולר בקרן. בנוסף למנורה מבטחים, ישנם משקיעים נוספים בקרן, כולל לאומי פרטנרס, קרן מכבי, CBG, Carilion Clinic, אחזקות מאיחוד האמירויות ומשקיעים פרטיים.
Investment
growth-positive
ALIVE and thriving: Pushing the boundaries of health technology
ALIVE, a $150 million health-tech fund, is investing in medical devices and digital health. The fund focuses on mid- to late-stage health technology and works with companies that have a mature vision. ALIVE collaborates with Assuta chain of hospitals, the Maccabi health system, and Carilion Clinic in the United States. The fund has invested in companies like Medisafe, Innovalve Bio Medical, and Magenta Medical. ALIVE is evaluating additional companies for possible investments. The fund is global, with investors from Israel, the United States, and other countries. ALIVE is looking forward to making more face-to-face contacts among investors and developers as the world recovers from COVID-19.
InvestmentPartners
growth-positive
Israel's Bank Leumi leads $150 million round in medtech fund ALIVE as an anchor investor
Leumi Partners has led a $150 million round for ALIVE HealthTech Fund, a medtech investment fund. The fund, led by former Israeli healthcare system officials, aims to focus on mature companies in the fields of medical technology, medical equipment, and telemedicine. Leumi Partners invested $10 million in the fund, which also received investments from Maccabi Fund, Consensus Business Group, and Carilion Clinics. ALIVE HealthTech Fund plans to lead 10-15 rounds of investment within the next four years, with investments ranging from $10 million to $30 million. The funds first investment will be in a cardiology company.
InvestmentPartners
growth-positive
New Israeli Medical Technologies Fund Aims to Close $150 Million in Commitments by End of Year
ALIVE HealthTech Fund, a joint venture involving CBG Asset Management, is aiming to raise $50 million in commitments by the end of the quarter and $150 million by the end of 2019. The fund will invest in medical technologies and has already received $32 million in commitments from its founding partners. The partners of the fund include Maccabi Healthcare Services, Assuta, CBG Asset Management, and Michel Habib. Maccabi and Assuta will provide access to clinical trials and medical databases. The fund will focus on late-stage startups in the domains of medical devices and software, digital health, personalized healthcare, nutrition-related technologies, and medical cannabis.
PartnersInvestment
